_id
6915ec28bc934aba376b1d44
Ticker
RAPT
Name
RAPT Therapeutics Inc
Exchange
NASDAQ
Address
561 Eccles Avenue, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.rapt.com
Description
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Last Close
35.28
Volume
814808
Current Price
36.8
Change
4.3083900226757255
Last Updated
2025-12-03T12:43:29.443Z
Image
data:image/webp;base64,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
Ipo Date
2019-10-31T00:00:00.000Z
Market Cap
895892544
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.361
Sentiment Sources
1
Rating
3.2857
Target Price
65
Strong Buy
1
Buy
1
Hold
4
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
19371000
Operating Income
-19371000
Interest Expense
-
Pretax Income
-17580000
Net Income
-17580000
Eps
-0.6520020114892545
Dividends Per Share
-
Shares Outstanding
27710871
Income Tax Expense
-
EBITDA
-17375000
Operating Margin
-
Total Other Income Expense Net
1791000
Cash
37930000
Short Term Investments
119414000
Receivables
-
Inventories
-
Total Current Assets
161045000
Property Plant Equipment
2648000
Total Assets
165739000
Payables
2102000
Short Term Debt
2209000
Long Term Debt
-
Total Liabilities
13762000
Equity
151977000
Depreciation
205000
Change In Working Capital
145000
Cash From Operations
-12458000
Capital Expenditures
0
Cash From Investing
8466000
Cash From Financing
36000
Net Change In Cash
-3956000
PE
-
PB
6.528898041150963
ROE
-11.567539825105115
ROA
-10.607038777837444
FCF
-12458000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
19371000
Quarters > 0 > income Statement > operating Income
-19371000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-17580000
Quarters > 0 > income Statement > net Income
-17580000
Quarters > 0 > income Statement > eps
-0.6520020114892545
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26963107
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-17375000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1791000
Quarters > 0 > balance Sheet > cash
37930000
Quarters > 0 > balance Sheet > short Term Investments
119414000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
161045000
Quarters > 0 > balance Sheet > property Plant Equipment
2648000
Quarters > 0 > balance Sheet > total Assets
165739000
Quarters > 0 > balance Sheet > payables
2102000
Quarters > 0 > balance Sheet > short Term Debt
2209000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13762000
Quarters > 0 > balance Sheet > equity
151977000
Quarters > 0 > cash Flow > net Income
-17580000
Quarters > 0 > cash Flow > depreciation
205000
Quarters > 0 > cash Flow > change In Working Capital
145000
Quarters > 0 > cash Flow > cash From Operations
-12458000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
8466000
Quarters > 0 > cash Flow > cash From Financing
36000
Quarters > 0 > cash Flow > net Change In Cash
-3956000
Quarters > 0 > ratios > PE
-0.6520020114892545
Quarters > 0 > ratios > PB
6.528898041150963
Quarters > 0 > ratios > ROE
-11.567539825105115
Quarters > 0 > ratios > ROA
-10.607038777837444
Quarters > 0 > ratios > FCF
-12458000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
200000
Quarters > 1 > income Statement > gross Profit
-200000
Quarters > 1 > income Statement > operating Expenses
19335000
Quarters > 1 > income Statement > operating Income
-19535000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-17643000
Quarters > 1 > income Statement > net Income
-17643000
Quarters > 1 > income Statement > eps
-0.6546627961548589
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
26949752
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-17443000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1892000
Quarters > 1 > balance Sheet > cash
41886000
Quarters > 1 > balance Sheet > short Term Investments
127061000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
172859000
Quarters > 1 > balance Sheet > property Plant Equipment
3278000
Quarters > 1 > balance Sheet > total Assets
178410000
Quarters > 1 > balance Sheet > payables
4189000
Quarters > 1 > balance Sheet > short Term Debt
2205000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
14002000
Quarters > 1 > balance Sheet > equity
164408000
Quarters > 1 > cash Flow > net Income
-17643000
Quarters > 1 > cash Flow > depreciation
228000
Quarters > 1 > cash Flow > change In Working Capital
1863000
Quarters > 1 > cash Flow > cash From Operations
-11271000
Quarters > 1 > cash Flow > capital Expenditures
40000
Quarters > 1 > cash Flow > cash From Investing
-7261000
Quarters > 1 > cash Flow > cash From Financing
161000
Quarters > 1 > cash Flow > net Change In Cash
-18371000
Quarters > 1 > ratios > PE
-0.6546627961548589
Quarters > 1 > ratios > PB
6.032254352586248
Quarters > 1 > ratios > ROE
-10.731229623862585
Quarters > 1 > ratios > ROA
-9.889019673785102
Quarters > 1 > ratios > FCF
-11311000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
19265000
Quarters > 2 > income Statement > operating Income
-19265000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17165000
Quarters > 2 > income Statement > net Income
-17165000
Quarters > 2 > income Statement > eps
-0.6374812771210402
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
26926281
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-19013000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2100000
Quarters > 2 > balance Sheet > cash
60257000
Quarters > 2 > balance Sheet > short Term Investments
119019000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
183196000
Quarters > 2 > balance Sheet > property Plant Equipment
3985000
Quarters > 2 > balance Sheet > total Assets
187570000
Quarters > 2 > balance Sheet > payables
1295000
Quarters > 2 > balance Sheet > short Term Debt
2315000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10198000
Quarters > 2 > balance Sheet > equity
177372000
Quarters > 2 > cash Flow > net Income
-17165000
Quarters > 2 > cash Flow > depreciation
252000
Quarters > 2 > cash Flow > change In Working Capital
-40040000
Quarters > 2 > cash Flow > cash From Operations
-52414000
Quarters > 2 > cash Flow > capital Expenditures
43000
Quarters > 2 > cash Flow > cash From Investing
-57064000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-109478000
Quarters > 2 > ratios > PE
-0.6374812771210402
Quarters > 2 > ratios > PB
5.586491333468642
Quarters > 2 > ratios > ROE
-9.67740116816634
Quarters > 2 > ratios > ROA
-9.15125019992536
Quarters > 2 > ratios > FCF
-52457000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
54465000
Quarters > 3 > income Statement > operating Income
-54465000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-53249000
Quarters > 3 > income Statement > net Income
-53249000
Quarters > 3 > income Statement > eps
-9.124322731213823
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5835940
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-54178000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1216000
Quarters > 3 > balance Sheet > cash
169735000
Quarters > 3 > balance Sheet > short Term Investments
61320000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
235236000
Quarters > 3 > balance Sheet > property Plant Equipment
4699000
Quarters > 3 > balance Sheet > total Assets
240325000
Quarters > 3 > balance Sheet > payables
1275000
Quarters > 3 > balance Sheet > short Term Debt
2422000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
50421000
Quarters > 3 > balance Sheet > equity
189904000
Quarters > 3 > cash Flow > net Income
-53249000
Quarters > 3 > cash Flow > depreciation
287000
Quarters > 3 > cash Flow > change In Working Capital
37882000
Quarters > 3 > cash Flow > cash From Operations
-10437000
Quarters > 3 > cash Flow > capital Expenditures
1000
Quarters > 3 > cash Flow > cash From Investing
-843000
Quarters > 3 > cash Flow > cash From Financing
143115000
Quarters > 3 > cash Flow > net Change In Cash
131835000
Quarters > 3 > ratios > PE
-9.124322731213823
Quarters > 3 > ratios > PB
1.1309008341056532
Quarters > 3 > ratios > ROE
-28.03995703092089
Quarters > 3 > ratios > ROA
-22.15707895558098
Quarters > 3 > ratios > FCF
-10438000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3539000
Annuals > 0 > income Statement > gross Profit
-3539000
Annuals > 0 > income Statement > operating Expenses
136101000
Annuals > 0 > income Statement > operating Income
-136101000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-129865000
Annuals > 0 > income Statement > net Income
-129865000
Annuals > 0 > income Statement > eps
-25.488004063478506
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5095142
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-134898000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
6236000
Annuals > 0 > balance Sheet > cash
169735000
Annuals > 0 > balance Sheet > short Term Investments
61320000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
235236000
Annuals > 0 > balance Sheet > property Plant Equipment
4699000
Annuals > 0 > balance Sheet > total Assets
240325000
Annuals > 0 > balance Sheet > payables
1275000
Annuals > 0 > balance Sheet > short Term Debt
2422000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
50421000
Annuals > 0 > balance Sheet > equity
189904000
Annuals > 0 > cash Flow > net Income
-129865000
Annuals > 0 > cash Flow > depreciation
1203000
Annuals > 0 > cash Flow > change In Working Capital
25907000
Annuals > 0 > cash Flow > cash From Operations
-83297000
Annuals > 0 > cash Flow > capital Expenditures
122000
Annuals > 0 > cash Flow > cash From Investing
52702000
Annuals > 0 > cash Flow > cash From Financing
152852000
Annuals > 0 > cash Flow > net Change In Cash
122257000
Annuals > 0 > ratios > PE
-25.488004063478506
Annuals > 0 > ratios > PB
0.8674169099123766
Annuals > 0 > ratios > ROE
-68.38455219479316
Annuals > 0 > ratios > ROA
-54.037241235826485
Annuals > 0 > ratios > FCF
-83419000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3551000
Annuals > 1 > income Statement > gross Profit
-3551000
Annuals > 1 > income Statement > operating Expenses
127062000
Annuals > 1 > income Statement > operating Income
-127062000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-116798000
Annuals > 1 > income Statement > net Income
-116798000
Annuals > 1 > income Statement > eps
-24.372166009010343
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4792270
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-125846000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
10264000
Annuals > 1 > balance Sheet > cash
47478000
Annuals > 1 > balance Sheet > short Term Investments
111384000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
161782000
Annuals > 1 > balance Sheet > property Plant Equipment
7676000
Annuals > 1 > balance Sheet > total Assets
173329000
Annuals > 1 > balance Sheet > payables
5176000
Annuals > 1 > balance Sheet > short Term Debt
2448000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
26294000
Annuals > 1 > balance Sheet > equity
147035000
Annuals > 1 > cash Flow > net Income
-116798000
Annuals > 1 > cash Flow > depreciation
3551000
Annuals > 1 > cash Flow > change In Working Capital
5499000
Annuals > 1 > cash Flow > cash From Operations
-97048000
Annuals > 1 > cash Flow > capital Expenditures
1125000
Annuals > 1 > cash Flow > cash From Investing
104133000
Annuals > 1 > cash Flow > cash From Financing
1447000
Annuals > 1 > cash Flow > net Change In Cash
8532000
Annuals > 1 > ratios > PE
-24.372166009010343
Annuals > 1 > ratios > PB
1.053722508926446
Annuals > 1 > ratios > ROE
-79.43550855238549
Annuals > 1 > ratios > ROA
-67.38514616711572
Annuals > 1 > ratios > FCF
-98173000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1527000
Annuals > 2 > income Statement > cost Of Revenue
2807000
Annuals > 2 > income Statement > gross Profit
1527000
Annuals > 2 > income Statement > operating Expenses
87322000
Annuals > 2 > income Statement > operating Income
-85795000
Annuals > 2 > income Statement > interest Expense
1047000
Annuals > 2 > income Statement > pretax Income
-83838000
Annuals > 2 > income Statement > net Income
-81881000
Annuals > 2 > income Statement > eps
-20.13029956607786
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4067550
Annuals > 2 > income Statement > income Tax Expense
-1957000
Annuals > 2 > income Statement > EBITDA
-84748000
Annuals > 2 > income Statement > operating Margin
-5618.533071381794
Annuals > 2 > income Statement > total Other Income Expense Net
1957000
Annuals > 2 > balance Sheet > cash
38946000
Annuals > 2 > balance Sheet > short Term Investments
210122000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
252694000
Annuals > 2 > balance Sheet > property Plant Equipment
9479000
Annuals > 2 > balance Sheet > total Assets
266209000
Annuals > 2 > balance Sheet > payables
3365000
Annuals > 2 > balance Sheet > short Term Debt
2171000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
21043000
Annuals > 2 > balance Sheet > equity
245166000
Annuals > 2 > cash Flow > net Income
-83838000
Annuals > 2 > cash Flow > depreciation
1047000
Annuals > 2 > cash Flow > change In Working Capital
-1335000
Annuals > 2 > cash Flow > cash From Operations
-70771000
Annuals > 2 > cash Flow > capital Expenditures
845000
Annuals > 2 > cash Flow > cash From Investing
-45490000
Annuals > 2 > cash Flow > cash From Financing
131180000
Annuals > 2 > cash Flow > net Change In Cash
14919000
Annuals > 2 > ratios > PE
-20.13029956607786
Annuals > 2 > ratios > PB
0.5363871478916326
Annuals > 2 > ratios > ROE
-33.39818735061142
Annuals > 2 > ratios > ROA
-30.75816369844746
Annuals > 2 > ratios > FCF
-71616000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-46.89980353634578
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3813000
Annuals > 3 > income Statement > cost Of Revenue
996000
Annuals > 3 > income Statement > gross Profit
3813000
Annuals > 3 > income Statement > operating Expenses
73022000
Annuals > 3 > income Statement > operating Income
-69209000
Annuals > 3 > income Statement > interest Expense
996000
Annuals > 3 > income Statement > pretax Income
-69204000
Annuals > 3 > income Statement > net Income
-68208000
Annuals > 3 > income Statement > eps
-19.921782585964678
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3423790
Annuals > 3 > income Statement > income Tax Expense
-996000
Annuals > 3 > income Statement > EBITDA
-68213000
Annuals > 3 > income Statement > operating Margin
-1815.0799895095727
Annuals > 3 > income Statement > total Other Income Expense Net
5000
Annuals > 3 > balance Sheet > cash
24027000
Annuals > 3 > balance Sheet > short Term Investments
165627000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
192973000
Annuals > 3 > balance Sheet > property Plant Equipment
2741000
Annuals > 3 > balance Sheet > total Assets
198636000
Annuals > 3 > balance Sheet > payables
1999000
Annuals > 3 > balance Sheet > short Term Debt
6326000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
12256000
Annuals > 3 > balance Sheet > equity
186380000
Annuals > 3 > cash Flow > net Income
-69204000
Annuals > 3 > cash Flow > depreciation
996000
Annuals > 3 > cash Flow > change In Working Capital
-4298000
Annuals > 3 > cash Flow > cash From Operations
-61026000
Annuals > 3 > cash Flow > capital Expenditures
755000
Annuals > 3 > cash Flow > cash From Investing
-81347000
Annuals > 3 > cash Flow > cash From Financing
141482000
Annuals > 3 > cash Flow > net Change In Cash
-891000
Annuals > 3 > ratios > PE
-19.921782585964678
Annuals > 3 > ratios > PB
0.5939002612941303
Annuals > 3 > ratios > ROE
-36.596201309153344
Annuals > 3 > ratios > ROA
-34.338186431462574
Annuals > 3 > ratios > FCF
-61781000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-16.20272751114608
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.6520020114892545
Valuation > metrics > PB
6.528898041150963
Valuation > final Score
20
Valuation > verdict
117.6% Overvalued
Profitability > metrics > ROE
-11.567539825105115
Profitability > metrics > ROA
-10.916203545592847
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.0905531758094975
Risk > metrics > Interest Coverage
-94.49268292682927
Risk > final Score
-318
Risk > verdict
High
Liquidity > metrics > Current Ratio
37.356761772210625
Liquidity > metrics > Quick Ratio
37.356761772210625
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
24.135086665313583
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-331
Prev Risks > 1
18
Prev Risks > 2
-175
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:16:25.929Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.65
Earnings History > 0 > eps Estimate
-0.1085
Earnings History > 0 > eps Difference
-0.5415
Earnings History > 0 > surprise Percent
-499.0783
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.65
Earnings History > 1 > eps Estimate
-0.09
Earnings History > 1 > eps Difference
-0.56
Earnings History > 1 > surprise Percent
-622.2222
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.08
Earnings History > 2 > eps Estimate
-0.1361
Earnings History > 2 > eps Difference
0.0561
Earnings History > 2 > surprise Percent
41.2197
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-05
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.22
Earnings History > 3 > eps Estimate
-0.3551
Earnings History > 3 > eps Difference
-0.8649
Earnings History > 3 > surprise Percent
-243.5652
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4738
Earnings History > 4 > eps Estimate
-0.56
Earnings History > 4 > eps Difference
0.0862
Earnings History > 4 > surprise Percent
15.3929
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.71
Earnings History > 5 > eps Estimate
-0.72
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
1.3889
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.79
Earnings History > 6 > eps Estimate
-0.81
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
2.4691
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.8
Earnings History > 7 > eps Estimate
-0.86
Earnings History > 7 > eps Difference
0.06
Earnings History > 7 > surprise Percent
6.9767
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.82
Earnings History > 8 > eps Estimate
-0.75
Earnings History > 8 > eps Difference
-0.07
Earnings History > 8 > surprise Percent
-9.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.66
Earnings History > 9 > eps Estimate
-0.78
Earnings History > 9 > eps Difference
0.12
Earnings History > 9 > surprise Percent
15.3846
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.76
Earnings History > 10 > eps Estimate
-0.68
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-11.7647
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-14
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.64
Earnings History > 11 > eps Estimate
-0.65
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
1.5385
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.63
Earnings History > 12 > eps Estimate
-0.67
Earnings History > 12 > eps Difference
0.04
Earnings History > 12 > surprise Percent
5.9701
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.62
Earnings History > 13 > eps Estimate
-0.75
Earnings History > 13 > eps Difference
0.13
Earnings History > 13 > surprise Percent
17.3333
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.69
Earnings History > 14 > eps Estimate
-0.68
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-1.4706
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.61
Earnings History > 15 > eps Estimate
-0.66
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
7.5758
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.63
Earnings History > 16 > eps Estimate
-0.62
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-1.6129
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-11
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.63
Earnings History > 17 > eps Estimate
-0.67
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
5.9701
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-11
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.66
Earnings History > 18 > eps Estimate
-0.62
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-6.4516
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.52
Earnings History > 19 > eps Estimate
-0.59
Earnings History > 19 > eps Difference
0.07
Earnings History > 19 > surprise Percent
11.8644
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-16
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.6
Earnings History > 20 > eps Estimate
-0.57
Earnings History > 20 > eps Difference
-0.03
Earnings History > 20 > surprise Percent
-5.2632
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-13
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.51
Earnings History > 21 > eps Estimate
-0.58
Earnings History > 21 > eps Difference
0.07
Earnings History > 21 > surprise Percent
12.069
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.56
Earnings History > 22 > eps Estimate
-0.43
Earnings History > 22 > eps Difference
-0.13
Earnings History > 22 > surprise Percent
-30.2326
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-30
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.82
Earnings History > 23 > eps Estimate
-0.69
Earnings History > 23 > eps Difference
-0.13
Earnings History > 23 > surprise Percent
-18.8406
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-11
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-12.41
Earnings History > 24 > eps Estimate
-0.64
Earnings History > 24 > eps Difference
-11.77
Earnings History > 24 > surprise Percent
-1839.0625
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-07-24
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.36
Earnings History > 25 > eps Estimate
-0.6
Earnings History > 25 > eps Difference
0.24
Earnings History > 25 > surprise Percent
40
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AH.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Maintains Target Price $72 富途牛牛
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$65
Analyst Picks
Strong Buy
1
Buy
1
Hold
4
Sell
1
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 99.81% of the total shares of RAPT Therapeutics Inc
1.
Medicxi Ventures Management (Jersey) Ltd(16.8946%)
since
2025/06/30
2.
Orbimed Advisors, LLC(9.9282%)
since
2025/06/30
3.
TCG Crossover Management, LLC(9.8942%)
since
2025/06/30
4.
Foresite Capital Management VI LLC(9.4481%)
since
2025/06/30
5.
RTW INVESTMENTS, LLC(8.8917%)
since
2025/06/30
6.
Bvf Inc(6.9821%)
since
2025/06/30
7.
Nantahala Capital Management, LLC(5.7542%)
since
2025/06/30
8.
Vanguard Group Inc(5.3214%)
since
2025/06/30
9.
ADAR1 Capital Management LLC(4.7359%)
since
2025/06/30
10.
Deep Track Capital, LP(4.5437%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(4.0551%)
since
2025/07/31
12.
Redmile Group, LLC(3.8136%)
since
2025/06/30
13.
FCPM III SERVICES BV(2.6616%)
since
2025/06/30
14.
Perceptive Advisors LLC(1.1119%)
since
2025/06/30
15.
Column Group LLC(1.0042%)
since
2025/03/31
16.
Geode Capital Management, LLC(0.8469%)
since
2025/06/30
17.
Vanguard Institutional Extnd Mkt Idx Tr(0.723%)
since
2025/07/31
18.
BlackRock Inc(0.5433%)
since
2025/06/30
19.
Euclidean Capital LLC(0.4972%)
since
2025/06/30
20.
Renaissance Technologies Corp(0.3778%)
since
2025/06/30
21.
Fidelity Extended Market Index(0.3405%)
since
2025/07/31
22.
Two Sigma Investments LLC(0.2638%)
since
2025/06/30
23.
Extended Equity Market Fund K(0.1328%)
since
2025/06/30
24.
Fidelity Total Market Index(0.1223%)
since
2025/07/31
25.
Fidelity Series Total Market Index(0.0898%)
since
2025/07/31
26.
Fidelity Nasdaq Composite Index(0.0858%)
since
2025/07/31
27.
Spartan Extended Market Index Pool F(0.0805%)
since
2025/07/31
28.
AJU IB Investment Co Ltd(0.0752%)
since
2025/03/31
29.
NT Ext Equity Mkt Idx Fd - NL(0.0738%)
since
2025/06/30
30.
Northern Trust Extended Eq Market Idx(0.0735%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - L(0.0735%)
since
2025/06/30
32.
Schwab Total Stock Market Index(0.0605%)
since
2025/07/31
33.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0573%)
since
2025/06/30
34.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.054%)
since
2025/07/31
35.
Invesco RAFI US 1500 Small-Mid ETF(0.0516%)
since
2025/08/29
36.
Goldman Sachs Small Cap Eq Insghts Instl(0.0473%)
since
2025/04/30
37.
Goldman Sachs Small Cp Val Insghts Instl(0.0468%)
since
2025/04/30
38.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0255%)
since
2025/03/31
39.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0179%)
since
2024/12/31
40.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0059%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.65
EPS Estimate
-0.1085
EPS Difference
-0.5415
Surprise Percent
-499.0783%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.